Genocea Biosciences (GNCAQ) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock Genocea Biosciences Short Interest DataGenocea Biosciences (GNCAQ) has a short interest of 195,100 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 1,951.0, indicating that it would take 1,951.0 days of the average trading volume of 1,863 shares to cover all short positions.Current Short Interest195,100 sharesPrevious Short Interest195,100 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$0.00Short Interest Ratio1,951.0 Days to CoverLast Record DateMay 15, 2025Outstanding Shares58,730,000 sharesPercentage of Shares Shorted0.33%Today's Trading Volume0 sharesAverage Trading Volume1,863 sharesToday's Volume Vs. Average0% Short Selling Genocea Biosciences? Sign up to receive the latest short interest report for Genocea Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGNCAQ Short Interest Over TimeGNCAQ Days to Cover Over TimeGNCAQ Percentage of Float Shorted Over Time Genocea Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/2025195,100 shares $0.00 No ChangeN/A1951 $0.00 4/30/2025195,100 shares $0.00 No ChangeN/A0 $0.00 4/15/2025195,100 shares $0.00 No ChangeN/A1951 $0.00 3/14/2025195,100 shares $0.00 No ChangeN/A975.5 $0.00 2/28/2025195,100 shares $0.00 No ChangeN/A975.5 $0.00 2/14/2025195,100 shares $0.00 No ChangeN/A975.5 $0.00 1/31/2025195,100 shares $0.00 No ChangeN/A216.8 $0.00 1/15/2025195,100 shares $0.00 No ChangeN/A162.6 $0.00 GNCAQ Short Interest - Frequently Asked Questions What is Genocea Biosciences' current short interest? Short interest is the volume of Genocea Biosciences shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 195,100 shares of GNCAQ short. Learn More on Genocea Biosciences' current short interest. What is a good short interest ratio for Genocea Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GNCAQ shares currently have a short interest ratio of 1,951.0. Learn More on Genocea Biosciences's short interest ratio. How does Genocea Biosciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Genocea Biosciences: Aridis Pharmaceuticals, Inc. (0.00%), Scopus BioPharma Inc. (0.02%), eFFECTOR Therapeutics, Inc. (0.12%), Evelo Biosciences, Inc. (0.04%), Comera Life Sciences Holdings, Inc. (0.01%), Statera Biopharma, Inc. (0.15%), Ampio Pharmaceuticals, Inc. (0.01%), Calithera Biosciences, Inc. (0.40%), Clever Leaves Holdings Inc. (0.48%), OncoSec Medical Incorporated (0.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks. What does it mean to sell short Genocea Biosciences stock? Short selling GNCAQ is an investing strategy that aims to generate trading profit from Genocea Biosciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Genocea Biosciences? A short squeeze for Genocea Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GNCAQ, which in turn drives the price of the stock up even further. How often is Genocea Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNCAQ, twice per month. The most recent reporting period available is May, 15 2025. More Short Interest Resources from MarketBeat Related Companies Aridis Pharmaceuticals Short Squeeze Scopus BioPharma Short Squeeze eFFECTOR Therapeutics Short Squeeze Evelo Biosciences Short Squeeze Comera Life Sciences Short Squeeze Statera Biopharma Short Squeeze Ampio Pharmaceuticals Short Squeeze Calithera Biosciences Short Squeeze Clever Leaves Short Squeeze OncoSec Medical Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GNCAQ) was last updated on 6/6/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Wealth Reset: Could You Be The First Beneficiary?Trump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major shift is coming this July — and Wall Street isn't waiting around. Thanks to a new rule going into e...American Alternative | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredHow to target 627% gains from Trump’s tweetsPresident Trump is shaking up the market with his tweets and Truth Social posts... But while this chaos has...Monument Traders Alliance | SponsoredThe Age of Chaos has begunThis is one of the most confusing markets in history. We have entered an Age of Chaos. And you must take...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genocea Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genocea Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.